13-109179596-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001198950.3(MYO16):c.5378C>T(p.Ser1793Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,886 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001198950.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO16 | NM_001198950.3 | c.5378C>T | p.Ser1793Leu | missense_variant | 34/35 | ENST00000457511.7 | NP_001185879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO16 | ENST00000457511.7 | c.5378C>T | p.Ser1793Leu | missense_variant | 34/35 | 1 | NM_001198950.3 | ENSP00000401633.3 | ||
MYO16 | ENST00000356711.7 | c.5312C>T | p.Ser1771Leu | missense_variant | 34/35 | 1 | ENSP00000349145.2 | |||
MYO16-AS1 | ENST00000439299.1 | n.30-12292G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152136Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000370 AC: 93AN: 251470Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135904
GnomAD4 exome AF: 0.000222 AC: 325AN: 1461632Hom.: 1 Cov.: 30 AF XY: 0.000198 AC XY: 144AN XY: 727114
GnomAD4 genome AF: 0.000243 AC: 37AN: 152254Hom.: 1 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.5378C>T (p.S1793L) alteration is located in exon 34 (coding exon 34) of the MYO16 gene. This alteration results from a C to T substitution at nucleotide position 5378, causing the serine (S) at amino acid position 1793 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at